Human 45,X fibroblast transcriptome reveals distinct differentially expressed genes including long noncoding RNAs potentially associated with the pathophysiology of turner syndrome

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Rajpathak, Shriram N ^a   Vellarikkal, Shamsudheen Karuthedath ^b,c   Patowary, Ashok ^b   Scaria, Vinod ^b,c   Sivasubbu, Sridhar ^b,c   Deobagkar, Deepti D ^a  

^a UNIVERSITY OF PUNE   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^c ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; TRANSCRIPTOME; BIOLOGICAL MARKER; MESSENGER RNA;

ARTICLE; BONE DEVELOPMENT; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GLUCOSE METABOLISM; GONAD DEVELOPMENT; HAPLOINSUFFICIENCY; HUMAN; HUMAN CELL; KARYOTYPE 45,X; KARYOTYPE 46,XX; MONOSOMY; PATHOPHYSIOLOGY; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; TURNER SYNDROME; VALIDATION STUDY; CELL CULTURE; DNA MICROARRAY; GENETICS; MALE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; X CHROMOSOMAL INHERITANCE;

BIOMARKERS; CELLS, CULTURED; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; GENES, X-LINKED; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, MESSENGER; TRANSCRIPTOME; TURNER SYNDROME;

EID: 84903177206     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100076     Document Type: Article

References (80)

1. Arthold S, Kurowski A, Wutz A (2011) Mechanistic insights into chromosome-wide silencing in X inactivation. Human genetics 130: 295-305.
2. Carmona-Mora P, Walz K (2010) Retinoic acid induced 1, RAI1: A dosage sensitive gene related to neurobehavioral alterations including autistic behavior. Current genomics 11: 607.
3. Birchler JA, Veitia RA (2012) Gene balance hypothesis: Connecting issues of dosage sensitivity across biological disciplines. Proceedings of the National Academy of Sciences 109: 14746-14753.
4. Feuk L, Carson AR, Scherer SW (2006) Structural variation in the human genome. Nature Reviews Genetics 7: 85-97. (Pubitemid 43128895)
5. Beckmann JS, Estivill X, Antonarakis SE (2007) Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nature Reviews Genetics 8: 639-646. (Pubitemid 47077281)
6. Samur MK, Shah PK, Wang X, Minvielle S, Magrangeas F, et al. (2013) The shaping and functional consequences of the dosage effect landscape in multiple myeloma. BMC genomics 14: 672.
7. Valtorta E, Misale S, Sartore-Bianchi A, Nagtegaal ID, Paraf F, et al. (2013) KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. International Journal of Cancer.
8. Berger AH, Pandolfi PP (2011) Haplo-insufficiency: a driving force in cancer. The Journal of pathology 223: 138-147.
9. Ewart AK, Morris CA, Atkinson D, Jin W, Sternes K, et al. (1993) Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nature genetics 5: 11-16. (Pubitemid 23261511)
10. Mitchell JR, Wood E, Collins K (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402: 551-555.
11. Rovet J (2004) Turner syndrome: Genetic and hormonal factors contributing to a specific learning disability profile. Learning Disabilities Research & Practice 19: 133-145.
12. Sybert VP, McCauley E (2004) Turner's syndrome. New England Journal of Medicine 351: 1227-1238.
13. Zinn AR, Ross JL (1998) Turner syndrome and haploinsufficiency. Current opinion in genetics & development 8: 322-327. (Pubitemid 28340084)
14. Temple CM, Carney RA, Mullarkey S (1996) Frontal lobe function and executive skills in children with Turner's syndrome. Developmental Neuropsychology 12: 343-363. (Pubitemid 126473756)
15. Ellison JW, Wardak Z, Young MF, Robey PG, Laig-Webster M, et al. (1997) PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Human molecular genetics 6: 1341-1347. (Pubitemid 27351076)
16. Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, et al. (2000) The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Human molecular genetics 9: 695-702. (Pubitemid 30162753)
17. Bione S, Sala C, Manzini C, Arrigo G, Zuffardi O, et al. (1998) A Human Homologue of the Drosophila melanogaster diaphanous Gene Is Disrupted in a Patient with Premature Ovarian Failure: Evidence for Conserved Function in Oogenesis and Implications for Human Sterility. The American Journal of Human Genetics 62: 533-541. (Pubitemid 28164610)
18. Carrel L, Willard HF (2005) X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434: 400-404. (Pubitemid 40469185)
19. Li C-M, Guo M, Salas M, Schupf N, Silverman W, et al. (2006) Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC medical genetics 7: 24.
20. Tang Y, Schapiro MB, Franz DN, Patterson BJ, Hickey FJ, et al. (2004) Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome. Annals of neurology 56: 808-814. (Pubitemid 39578444)
21. Lockstone H, Harris L, Swatton J, Wayland M, Holland A, et al. (2007) Gene expression profiling in the adult Down syndrome brain. Genomics 90: 647-660. (Pubitemid 350166832)
22. Vawter MP, Harvey PD, DeLisi LE (2007) Dysregulation of X-linked gene expression in Klinefelter's syndrome and association with verbal cognition. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144: 728-734. (Pubitemid 47417200)
23. Aksglaede L, Skakkebaek NE, Juul A (2008) Abnormal sex chromosome constitution and longitudinal growth: serum levels of insulin-like growth factor (IGF)-I, IGF binding protein-3, luteinizing hormone, and testosterone in 109 males with 47, XXY, 47, XYY, or sex-determining region of the Y chromosome (SRY)-positive 46, XX karyotypes. Journal of Clinical Endocrinology & Metabolism 93: 169-176.
24. Zhang R, Hao L, Wang L, Chen M, Li W, et al. (2013) Gene expression analysis of induced pluripotent stem cells from aneuploid chromosomal syndromes. BMC Genomics 14: 1-13.
25. Højbjerg Gravholt C, Svenstrup B, Bennett P, Sandahl Christiansen J (1999) Reduced androgen levels in adult Turner syndrome: influence of female sex steroids and growth hormone status. Clinical endocrinology 50: 791-800. (Pubitemid 29284514)
26. Gravholt CH, Frystyk J, Flyvbjerg A, Ørskov H, Christiansen JS (2001) Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids. American Journal of Physiology-Endocrinology And Metabolism 280: E308-E314.
27. Visser JA, Hokken-Koelega AC, Zandwijken GR, Limacher A, Ranke MB, et al. (2013) Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Human Reproduction 28: 1899-1907.
28. Bakalov VK, Cheng C, Zhou J, Bondy CA (2009) X-chromosome gene dosage and the risk of diabetes in Turner syndrome. Journal of Clinical Endocrinology & Metabolism 94: 3289-3296.
29. Obermann-Borst SA, van Driel LM, Helbing WA, de Jonge R, Wildhagen MF, et al. (2011) Congenital heart defects and biomarkers of methylation in children: a case-control study. European journal of clinical investigation 41: 143-150.
30. Rajpathak SN, Deobagkar DD (2013) Evidence for epigenetic alterations in Turner syndrome opens up feasibility of new pharmaceutical interventions. Curr Pharm Des.
31. Kelkar A, Deobagkar D (2010) Methylation profile of genes on the human X chromosome. Epigenetics 5: 612-618.
32. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, et al. (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature protocols 7: 562-578.
33. Da Wei Huang BTS, Lempicki RA (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 4: 44-57.
34. Xu M, Qin Y, Qu J, Lu C, Wang Y, et al. (2013) Evaluation of Five Candidate Genes from GWAS for Association with Oligozoospermia in a Han Chinese Population. PloS one 8: e80374.
35. Denny P, Swift S, Connor F, Ashworth A (1992) An SRY-related gene expressed during spermatogenesis in the mouse encodes a sequence-specific DNA-binding protein. The EMBO journal 11: 3705.
36. Lefebvre V (2002) Toward understanding the functions of the two highly related Sox5 and Sox6 genes. Journal of bone and mineral metabolism 20: 121-130.
37. Kaushik K, Leonard VE, Shamsudheen K, Lalwani MK, Jalali S, et al. (2013) Dynamic Expression of Long Non-Coding RNAs (lncRNAs) in Adult Zebrafish. PloS one 8: e83616.
38. Li W, Wang X, Fan W, Zhao P, Chan Y-C, et al. (2012) Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes. Human molecular genetics 21: 32-45.
39. Fisher E, Beer-Romero P, Brown LG, Ridley A, McNeil JA, et al. (1990) Homologous ribosomal protein genes on the human X and Y chromosomes: escape from X inactivation and possible implications for Turner syndrome. Cell 63: 1205-1218. (Pubitemid 120035069)
40. Burgoyne PS (1989) Mammalian sex determination: thumbs down for zinc finger? Nature 342: 860-862.
41. Urbach A, Benvenisty N (2009) Studying early lethality of 45, XO (Turner's syndrome) embryos using human embryonic stem cells. PLoS One 4: e4175.
42. Bandyopadhyay A, Tsuji K, Cox K, Harfe BD, Rosen V, et al. (2006) Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS genetics 2: e216.
43. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, et al. (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). The journal of bone & joint surgery 85: 1544-1552. (Pubitemid 36951140)
44. Groeneveld E, Burger E (2000) Bone morphogenetic proteins in human bone regeneration. European Journal of Endocrinology 142: 9-21. (Pubitemid 30094193)
45. Hogan B (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes & development 10: 1580-1594.
46. McCoy RJ, Widaa A, Watters KM, Wuerstle M, Stallings RL, et al. (2013) Orchestrating Osteogenic Differentiation of Mesenchymal Stem Cells-Identification of Placental Growth Factor as a Mechanosensitive Gene with a Pro-Osteogenic Role. STEM CELLS 31: 2420-2431.
47. Maes C, Coenegrachts L, Stockmans I, Daci E, Luttun A, et al. (2006) Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. Journal of Clinical Investigation 116: 1230-1242.
48. Marrony S, Bassilana F, Seuwen K, Keller H (2003) Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells. Bone 33: 426-433. (Pubitemid 37103259)
49. Gerstenfeld LC, Einhorn TA (2004) COX inhibitors and their effects on bone healing. Expert opinion on drug safety 3: 131-136. (Pubitemid 38765196)
50. Myers L, Bhattacharya S, Herring P, Xing Z, Goorha S, et al. (2006) The isozyme-specific effects of cyclooxygenase-deficiency on bone in mice. Bone 39: 1048-1052. (Pubitemid 44528378)
51. Chen L, Jiang W, Huang J, He BC, Zuo GW, et al. (2010) Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. Journal of Bone and Mineral Research 25: 2447-2459.
52. Chao W, D'Amore PA (2008) IGF2: epigenetic regulation and role in development and disease. Cytokine & growth factor reviews 19: 111-120. (Pubitemid 351382280)
53. Bodine PV, Zhao W, Kharode YP, Bex FJ, Lambert A-J, et al. (2004) The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Molecular Endocrinology 18: 1222-1237. (Pubitemid 38591287)
54. Gaur T, Rich L, Lengner CJ, Hussain S, Trevant B, et al. (2006) Secreted frizzled related protein 1 regulates Wnt signaling for BMP2 induced chondrocyte differentiation. Journal of cellular physiology 208: 87-96. (Pubitemid 43848992)
55. Edelman E, Girirajan S, Finucane B, Patel P, Lupski J, et al. (2007) Gender, genotype, and phenotype differences in Smith-Magenis syndrome: a meta-analysis of 105 cases. Clinical genetics 71: 540-550. (Pubitemid 46831948)
56. Christiansen J, Kolte AM, Nielsen FC (2009) IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. Journal of molecular endocrinology 43: 187-195.
57. Rodríguez S, Gaunt TR, Dennison E, Chen X-h, Syddall HE, et al. (2005) Replication of IGF2-INS-TH*5 haplotype effect on obesity in older men and study of related phenotypes. European journal of human genetics 14: 109-116. (Pubitemid 43019091)
58. Böttcher Y, Körner A, Reinehr T, Enigk B, Kiess W, et al. (2006) ENPP1 variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in German obese children. Journal of Clinical Endocrinology & Metabolism 91: 4948-4952. (Pubitemid 44917332)
59. Meyre D, Bouatia-Naji N, Tounian A, Samson C, Lecoeur C, et al. (2005) Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nature genetics 37: 863-867. (Pubitemid 41077112)
60. Du K, Herzig S, Kulkarni RN, Montminy M (2003) TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300: 1574-1577. (Pubitemid 36682889)
61. Lleo A, Moroni L, Caliari L, Invernizzi P (2012) Autoimmunity and Turner's syndrome. Autoimmunity reviews 11: A538-A543.
62. Goldacre MJ, Seminog OO (2014) Turner syndrome and autoimmune diseases: record-linkage study. Archives of disease in childhood 99: 71-73.
63. Ogata T, Matsuo N, Nishimura G (2001) SHOX haploinsufficiency and overdosage: impact of gonadal function status. Journal of medical genetics 38: 1-6. (Pubitemid 32102315)
64. Luo C-W, Pisarska MD, Hsueh AJ (2005) Identification of a stanniocalcin paralog, stanniocalcin-2, in fish and the paracrine actions of stanniocalcin-2 in the mammalian ovary. Endocrinology 146: 469-476. (Pubitemid 40051773)
65. Luo C-W, Kawamura K, Klein C, Hsueh AJ (2004) Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: mediation through specific STC1 receptors. Molecular Endocrinology 18: 2085-2096. (Pubitemid 39006511)
66. Agretti P, De Marco G, Pinchera A, Vitti P, Bernal J, et al. (2007) Ras homolog enriched in striatum inhibits the functional activity of wild type thyrotropin, follicle-stimulating hormone, luteinizing hormone receptors and activating thyrotropin receptor mutations by altering their expression in COS-7 cells. Journal of endocrinological investigation 30: 279.
67. Pan J, Hu H, Zhou Z, Sun L, Peng L, et al. (2010) Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncology reports 24: 105-112.
68. Zhi-Yong1, L, Guang-Ling2, Z, Mei-Mei W, et al. (2011) MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation. Asian Pacific Journal of Cancer Prevention 12: 2819-2823.
69. Pacilli A, Ceccarelli C, Treré D, Montanaro L (2013) SnoRNA U50 levels are regulated by cell proliferation and rRNA transcription. International journal of molecular sciences 14: 14923-14935.
70. Tanaka R, Satoh H, Moriyama M, Satoh K, Morishita Y, et al. (2000) Intronic U50 small-nucleolar-RNA (snoRNA) host gene of no protein-coding potential is mapped at the chromosome breakpoint t (3; 6) (q27; q15) of human B-cell lymphoma. Genes to Cells 5: 277-287. (Pubitemid 30253178)
71. Dong X-Y, Rodriguez C, Guo P, Sun X, Talbot JT, et al. (2008) SnoRNA U50 is a candidate tumor-suppressor gene at 6q14. 3 with a mutation associated with clinically significant prostate cancer. Human molecular genetics 17: 1031-1042. (Pubitemid 351426037)
72. Mourtada-Maarabouni M, Pickard M, Hedge V, Farzaneh F, Williams G (2008) GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28: 195-208.
73. Farooque A, Atapattu N, Amarasena S, Högler W, English MW, et al. (2012) An association of craniopharyngioma in turner syndrome. Pediatric blood & cancer.
74. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA (2008) Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. The lancet oncology 9: 239-246.
75. Di Cunto F, Berto G (2013) Molecular Pathways of Down Syndrome Critical Region Genes.
76. Bhartiya D, Kapoor S, Jalali S, Sati S, Kaushik K, et al. (2012) Conceptual approaches for lncRNA drug discovery and future strategies. Expert opinion on drug discovery 7: 503-513.
77. Simms D, Cizdziel PE, Chomczynski P (1993) TRIzol: A new reagent for optimal single-step isolation of RNA. Focus 15: 532-535.
78. Cox MP, Peterson DA, Biggs PJ (2010) SolexaQA: At-a-glance quality assessment of Illumina second-generation sequencing data. BMC bioinformatics 11: 485.
79. Lohse M, Bolger AM, Nagel A, Fernie AR, Lunn JE, et al. (2012) RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics. Nucleic acids research 40: W622-W627.
80. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, et al. (2012) GENCODE: The reference human genome annotation for The ENCODE Project. Genome research 22: 1760-1774.